A Lisbon man is battling a rare brain cancer. It’ll be a long road to recovery and the treatment is going to be costly.

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Cash Position: Black Diamond ended the third quarter of 2024 with approximately $112.7 million in cash, cash equivalents, and investments compared to $131.4 million as of December 31, 2023. Net cash ...

Theo Burrell was diagnosed with incurable brain cancer at the age of just 35 - and now she's sadly shared that her tumours have grown.

The VASC-IMMUNE project addresses the interaction between endothelial and immune cells focusing on both melanoma, a malignant ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

CureVac (CVAC) announced that new and updated data will be shared in two oral presentations and four posters at the 12th International mRNA ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

As a surgical strategy for the management of glioblastoma, lobectomy improves overall survival and PFS by approximately 1 year, demonstrating its promise.

Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.

In July, the company announced results from the Phase II/III clinical trial, GBM-AGILE, in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed clinically ...